Serbia: taking a PCT application to grant costs an estimated US$2,387, plus about US$5,622 in renewal fees over the patent's life. The PCT national phase for Serbia must be entered within 30 months of the earliest priority date. A European patent, granted by the European Patent Office, can also be validated in Serbia; most patent protection there is obtained this way. Serbia is a leading patent market for pharmaceuticals and biotechnology. It is also one of the world's leading exporters of frozen fruit and nuts.
Most patent protection in Serbia is obtained through the European Patent Office: a European patent validated in Serbia. The figures on this page count only applications filed directly with Serbia's own patent office, so they understate its market. See Europe (EPO, 39 states).
Goods where Serbia is among the world's 3 largest exporters, has at least 15% of world exports, or that make up at least 25% of its own exports - of at least US$500m a year.
Our estimate is about US$2,387 to take a PCT application to grant in Serbia. That is about US$800 in official fees and US$1,587 in attorney fees. By stage: filing US$790, search US$160, examination request US$530, office action response US$420 and grant / issuance / publication US$488 (one office action response included). Renewal fees over the patent's life add an estimated US$5,622. These are estimates only, for a standard application (10 claims, 30 pages, a company applicant): the actual cost depends on the law firm and the application. Request a quote from a law firm on this site for an exact price.
The PCT national phase for Serbia must be entered within 30 months of the earliest priority date. A European patent, granted by the European Patent Office, can also be validated in Serbia; most patent protection there is obtained this way.
Serbia's 7 largest fields of technology by patent publications are pharmaceuticals (362 a year), organic fine chemistry (143 a year), biotechnology (126 a year), other special machines (80 a year), civil engineering (68 a year), medical technology (50 a year) and handling (50 a year). Within its region, it stands out for pharmaceuticals (#4 in Europe and Central Asia), biotechnology (#5 in Europe and Central Asia) and organic fine chemistry (#8 in Europe and Central Asia). Publications are growing fastest in other special machines (8% a year), civil engineering (6% a year) and medical technology (2% a year).
Serbia's GDP is US$100.0bn, of which services US$59.7bn, industry US$22.3bn (of which manufacturing US$11.4bn) and agriculture US$3.3bn. Spending a year: households US$62.4bn and health care US$6.4bn. Serbia's exports of goods came to US$34.9bn in 2024. Its 10 largest exports were insulated wire and cable (US$2.2bn, 6% of its exports, #19 in the world), copper ore (US$1.7bn, 5% of its exports, #12 in the world), refined copper (US$1.3bn, 4% of its exports, #20 in the world), tyres (US$1.1bn, 3% of its exports, #25 in the world), vehicle parts (US$1.0bn, 3% of its exports, #32 in the world), electric motors and generators (US$1.0bn, 3% of its exports, #16 in the world), electricity (US$1.0bn, 3% of its exports, #23 in the world), maize (US$696m, 2% of its exports, #11 in the world), frozen fruit and nuts (US$515m, 1% of its exports, #3 in the world) and seats (US$500m, 1% of its exports, #27 in the world). Where products are made, a patent there can stop infringing copies being made, not only being sold.
No law firms are listed for this country yet.
Is your firm missing? Add your law firm
Rank every country for your invention, see the costs and request a quote from a law firm.
Find the best countries for your patentPatent publications and PCT national phase entries: averages over recent years. Exports: customs trade statistics; re-export hubs are left out. Costs are estimates.